Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

Identification of a Corticohabenular Circuit Regulating Socially Directed Behavior.

Benekareddy M, Stachniak TJ, Bruns A, Knoflach F, von Kienlin M, Künnecke B, Ghosh A.

Biol Psychiatry. 2018 Apr 1;83(7):607-617. doi: 10.1016/j.biopsych.2017.10.032. Epub 2017 Dec 2.

PMID:
29336819
2.

A novel anesthesia regime enables neurofunctional studies and imaging genetics across mouse strains.

Petrinovic MM, Hankov G, Schroeter A, Bruns A, Rudin M, von Kienlin M, Künnecke B, Mueggler T.

Sci Rep. 2016 Apr 15;6:24523. doi: 10.1038/srep24523.

3.

Temporal profile of brain response to alprazolam in patients with generalized anxiety disorder.

Brown GG, Ostrowitzki S, Stein MB, von Kienlin M, Liu TT, Simmons A, Wierenga C, Stein OY, Bruns A, Bischoff-Grethe A, Paulus M.

Psychiatry Res. 2015 Sep 30;233(3):394-401. doi: 10.1016/j.pscychresns.2015.06.016. Epub 2015 Jun 30.

PMID:
26211623
4.

"Domain gauges": A reference system for multivariate profiling of brain fMRI activation patterns induced by psychoactive drugs in rats.

Bruns A, Mueggler T, Künnecke B, Risterucci C, Prinssen EP, Wettstein JG, von Kienlin M.

Neuroimage. 2015 May 15;112:70-85. doi: 10.1016/j.neuroimage.2015.02.032. Epub 2015 Feb 25.

PMID:
25724758
5.

Pharmacology of basimglurant (RO4917523, RG7090), a unique metabotropic glutamate receptor 5 negative allosteric modulator in clinical development for depression.

Lindemann L, Porter RH, Scharf SH, Kuennecke B, Bruns A, von Kienlin M, Harrison AC, Paehler A, Funk C, Gloge A, Schneider M, Parrott NJ, Polonchuk L, Niederhauser U, Morairty SR, Kilduff TS, Vieira E, Kolczewski S, Wichmann J, Hartung T, Honer M, Borroni E, Moreau JL, Prinssen E, Spooren W, Wettstein JG, Jaeschke G.

J Pharmacol Exp Ther. 2015 Apr;353(1):213-33. doi: 10.1124/jpet.114.222463. Epub 2015 Feb 9.

PMID:
25665805
6.

Preserved modular network organization in the sedated rat brain.

D'Souza DV, Jonckers E, Bruns A, Künnecke B, von Kienlin M, Van der Linden A, Mueggler T, Verhoye M.

PLoS One. 2014 Sep 2;9(9):e106156. doi: 10.1371/journal.pone.0106156. eCollection 2014.

7.

Neuropharmacological and neurobiological relevance of in vivo ¹H-MRS of GABA and glutamate for preclinical drug discovery in mental disorders.

Waschkies CF, Bruns A, Müller S, Kapps M, Borroni E, von Kienlin M, Rudin M, Künnecke B.

Neuropsychopharmacology. 2014 Sep;39(10):2331-9. doi: 10.1038/npp.2014.79. Epub 2014 Apr 3.

8.

Chronic metabotropic glutamate receptor 5 inhibition corrects local alterations of brain activity and improves cognitive performance in fragile X mice.

Michalon A, Bruns A, Risterucci C, Honer M, Ballard TM, Ozmen L, Jaeschke G, Wettstein JG, von Kienlin M, Künnecke B, Lindemann L.

Biol Psychiatry. 2014 Feb 1;75(3):189-97. doi: 10.1016/j.biopsych.2013.05.038. Epub 2013 Jul 30.

PMID:
23910948
9.

Imaging trait anxiety in high anxiety F344 rats: Focus on the dorsomedial prefrontal cortex.

Prinssen EP, Nicolas LB, Klein S, Grundschober C, Lopez-Lopez C, Kessler MS, Bruns A, von Kienlin M, Wettstein JG, Moreau JL, Risterucci C.

Eur Neuropsychopharmacol. 2012 Jun;22(6):441-51. doi: 10.1016/j.euroneuro.2011.11.001. Epub 2011 Dec 6.

PMID:
22153786
10.

On precise localization of boundaries between extended uniform objects in MRI: tooth imaging as an example.

Tymofiyeva O, Schmid F, von Kienlin M, Breuer FA, Rottner K, Boldt J, Richter EJ, Jakob PM.

MAGMA. 2011 Feb;24(1):19-28. doi: 10.1007/s10334-010-0229-4. Epub 2010 Sep 29.

PMID:
20878537
11.

Phosphorylation of Tau at S422 is enhanced by Abeta in TauPS2APP triple transgenic mice.

Grueninger F, Bohrmann B, Czech C, Ballard TM, Frey JR, Weidensteiner C, von Kienlin M, Ozmen L.

Neurobiol Dis. 2010 Feb;37(2):294-306. doi: 10.1016/j.nbd.2009.09.004. Epub 2009 Sep 23.

PMID:
19781645
12.

Cortical hypoperfusion in the B6.PS2APP mouse model for Alzheimer's disease: comprehensive phenotyping of vascular and tissular parameters by MRI.

Weidensteiner C, Metzger F, Bruns A, Bohrmann B, Kuennecke B, von Kienlin M.

Magn Reson Med. 2009 Jul;62(1):35-45. doi: 10.1002/mrm.21985.

13.

Validation of cerebral blood perfusion imaging as a modality for quantitative pharmacological MRI in rats.

Bruns A, Künnecke B, Risterucci C, Moreau JL, von Kienlin M.

Magn Reson Med. 2009 Jun;61(6):1451-8. doi: 10.1002/mrm.21779.

14.

Effects of aripiprazole/OPC-14597 on motor activity, pharmacological models of psychosis, and brain activity in rats.

Nordquist RE, Risterucci C, Moreau JL, von Kienlin M, Künnecke B, Maco M, Freichel C, Riemer C, Spooren W.

Neuropharmacology. 2008 Feb;54(2):405-16. Epub 2007 Oct 26.

PMID:
18054053
15.

Non-invasive analysis of gallbladder bile composition in cynomolgus monkeys using in vivo 1H magnetic resonance spectroscopy.

Künnecke B, Bruns A, von Kienlin M.

Biochim Biophys Acta. 2007 Apr;1771(4):544-9. Epub 2007 Jan 19.

PMID:
17303470
16.

Age and gender dependence of human cardiac phosphorus metabolites determined by SLOOP 31P MR spectroscopy.

Köstler H, Landschütz W, Koeppe S, Seyfarth T, Lipke C, Sandstede J, Spindler M, von Kienlin M, Hahn D, Beer M.

Magn Reson Med. 2006 Oct;56(4):907-11.

17.
18.

New experimental setup for studying strictly noninvasively skeletal muscle function in rat using 1H-magnetic resonance (MR) imaging and 31P-MR spectroscopy.

Giannesini B, Izquierdo M, Le Fur Y, Cozzone PJ, Fingerle J, Himber J, Künnecke B, Von Kienlin M, Bendahan D.

Magn Reson Med. 2005 Nov;54(5):1058-64.

19.

Functional magnetic resonance imaging reveals similar brain activity changes in two different animal models of schizophrenia.

Risterucci C, Jeanneau K, Schöppenthau S, Bielser T, Künnecke B, von Kienlin M, Moreau JL.

Psychopharmacology (Berl). 2005 Aug;180(4):724-34. Epub 2005 Sep 14.

PMID:
15726331
20.

Altered metabolic profile in the frontal cortex of PS2APP transgenic mice, monitored throughout their life span.

von Kienlin M, Künnecke B, Metzger F, Steiner G, Richards JG, Ozmen L, Jacobsen H, Loetscher H.

Neurobiol Dis. 2005 Feb;18(1):32-9.

PMID:
15649694
21.

Improved cardiac sodium MR imaging by density-weighted phase-encoding.

Greiser A, Haase A, von Kienlin M.

J Magn Reson Imaging. 2005 Jan;21(1):78-81.

PMID:
15611944
22.

Quantitative body composition analysis in awake mice and rats by magnetic resonance relaxometry.

Künnecke B, Verry P, Bénardeau A, von Kienlin M.

Obes Res. 2004 Oct;12(10):1604-15.

23.

Efficient k-space sampling by density-weighted phase-encoding.

Greiser A, von Kienlin M.

Magn Reson Med. 2003 Dec;50(6):1266-75.

24.

Natural abundance 13C-NMR spectroscopy for the quantitative determination of fecal fat.

Kunz P, Künnecke B, Kunz I, Lengsfeld H, von Kienlin M.

Clin Biochem. 2003 Oct;36(7):505-10.

PMID:
14563442
25.

Absolute concentrations of high-energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with (31)P-SLOOP magnetic resonance spectroscopy.

Beer M, Seyfarth T, Sandstede J, Landschütz W, Lipke C, Köstler H, von Kienlin M, Harre K, Hahn D, Neubauer S.

J Am Coll Cardiol. 2002 Oct 2;40(7):1267-74.

26.

Imaging of intracellular sodium with shift reagent aided (23)Na CSI in isolated rat hearts.

Weidensteiner C, Horn M, Fekete E, Neubauer S, von Kienlin M.

Magn Reson Med. 2002 Jul;48(1):89-96.

27.

[31P-MR spectroscopy of all regions of the human heart at 1.5 T with acquisition-weighted chemical shift imaging].

Köstler H, Beer M, Landschütz W, Buchner S, Sandstede J, Pabst T, Kenn W, Neubauer S, von Kienlin M, Hahn D.

Rofo. 2001 Dec;173(12):1093-8. German.

PMID:
11740669
28.

Application of Chemical Shift Imaging for Simultaneous and Fast Acquisition of NMR Spectra on Multiple Samples.

Ross A, Schlotterbeck G, Senn H, von Kienlin M.

Angew Chem Int Ed Engl. 2001 Sep 3;40(17):3243-3245. doi: 10.1002/1521-3773(20010903)40:17<3243::AID-ANIE3243>3.0.CO;2-F.

PMID:
29712067
29.

(31)P-MR Spectroscopy for the evaluation of energy metabolism in intact residual myocardium after acute myocardial infarction in humans.

Beer M, Buchner S, Sandstede J, Viehrig M, Lipke C, Krug A, Köstler H, Pabst T, Kenn W, Landschütz W, von Kienlin M, Harre K, Neubauer S, Hahn D.

MAGMA. 2001 Oct;13(2):70-5.

PMID:
11502420
30.

High glycolytic activity in rat glioma demonstrated in vivo by correlation peak 1H magnetic resonance imaging.

Ziegler A, von Kienlin M, Décorps M, Rémy C.

Cancer Res. 2001 Jul 15;61(14):5595-600.

31.

Cardiac metabolism and function in patients with multiple sclerosis: a combined 31P-MR-spectroscopy and MRI study.

Beer M, Sandstede J, Weilbach F, Spindler M, Buchner S, Krug A, Köstler H, Pabst T, Kenn W, Landschütz W, von Kienlin M, Toyka KV, Ertl G, Gold R, Hahn D.

Rofo. 2001 May;173(5):399-404.

PMID:
11414146
32.

Accurate phosphorus metabolite images of the human heart by 3D acquisition-weighted CSI.

Pohmann R, von Kienlin M.

Magn Reson Med. 2001 May;45(5):817-26.

33.

Detection of myocardial viability based on measurement of sodium content: A (23)Na-NMR study.

Horn M, Weidensteiner C, Scheffer H, Meininger M, de Groot M, Remkes H, Dienesch C, Przyklenk K, von Kienlin M, Neubauer S.

Magn Reson Med. 2001 May;45(5):756-64.

34.

Advances in human cardiac 31P-MR spectroscopy: SLOOP and clinical applications.

von Kienlin M, Beer M, Greiser A, Hahn D, Harre K, Köstler H, Landschütz W, Pabst T, Sandstede J, Neubauer S.

J Magn Reson Imaging. 2001 Apr;13(4):521-7. Review.

PMID:
11276095
35.

Absolute quantification of high energy phosphate metabolites in normal, hypertrophied and failing human myocardium.

Neubauer S, Beer M, Landschütz W, Sandstede J, Seyfarth T, Lipke C, Köstler H, Pabst TKenn W, Meininger M, von Kienlin M, Horn M, Harre K, Hahn D.

MAGMA. 2000 Nov;11(1-2):73-4. No abstract available.

PMID:
11186995
36.

Assessment of myocardial viability by 31P-MR-spectroscopy and 23Na-MR imaging.

Beer M, Sandstede J, Pabst T, Landschütz W, Harre K, von Kienlin M, Voelker W, Neubauer S, Hahn D.

MAGMA. 2000 Nov;11(1-2):44-6. No abstract available.

PMID:
11186983
37.

Use of 23Na MRS to discriminate viable from non viable tissue: experimental studies.

Horn M, Weidensteiner C, Scheffer H, Przyklenk K, von Kienlin M, Neubauer S.

MAGMA. 2000 Nov;11(1-2):42-3. No abstract available.

PMID:
11186982
38.

Methodological advances in cardiac 31P-MR spectroscopy.

von Kienlin M.

MAGMA. 2000 Nov;11(1-2):36-8. No abstract available.

PMID:
11186980
39.

Optimization of ECG-triggered 3D (23)Na MRI of the human heart.

Pabst T, Sandstede J, Beer M, Kenn W, Greiser A, von Kienlin M, Neubauer S, Hahn D.

Magn Reson Med. 2001 Jan;45(1):164-6.

40.

Altered energy metabolism after myocardial infarction assessed by 31P-MR-spectroscopy in humans.

Beer M, Sandstede J, Landschütz W, Viehrig M, Harre K, Horn M, Meininger M, Pabst T, Kenn W, Haase A, von Kienlin M, Neubauer S, Hahn D.

Eur Radiol. 2000;10(8):1323-8.

PMID:
10939500
41.

[Cardiac energy metabolism in heart valve diseases with 31P MR spectroscopy].

Beer M, Viehrig M, Seyfarth T, Sandstede J, Lipke C, Pabst T, Kenn W, Harre K, Horn M, Landschütz W, von Kienlin M, Neubauer S, Hahn D.

Radiologe. 2000 Feb;40(2):162-7. German.

PMID:
10758631
42.

Reduced (1)H-NMR visibility of creatine in isolated rat hearts.

Schneider J, Fekete E, Weisser A, Neubauer S, von Kienlin M.

Magn Reson Med. 2000 Apr;43(4):497-502.

43.

Three-dimensional (13)C-spectroscopic imaging in the isolated infarcted rat heart.

Weidensteiner C, Lanz T, Horn M, Neubauer S, Haase A, von Kienlin M.

J Magn Reson. 2000 Mar;143(1):17-23.

PMID:
10698641
44.

2D-spatial/2D-spectral spectroscopic imaging of intracerebral gliomas in rat brain.

von Kienlin M, Ziegler A, Le Fur Y, Rubin C, Dećorps M, Rémy C.

Magn Reson Med. 2000 Feb;43(2):211-9.

45.

Beyond k-space: spectral localization using higher order gradients.

Pohmann R, Rommel E, von Kienlin M.

J Magn Reson. 1999 Dec;141(2):197-206.

PMID:
10579943
46.

[The quantification of energy-rich phosphates in healthy and damaged heart muscle by SLOOP 31P-MR spectroscopy. Spatial localization with optimal pointspread function].

Beer M, Landschütz W, Meininger M, Seyfarth T, Viehrig M, Sandstede J, Pabst T, Kenn W, Horn M, Harre K, von Kienlin M, Neubauer S, Hahn D.

Rofo. 1999 Jul;171(1):65-8. German.

PMID:
10464508
47.

Concentrations of human cardiac phosphorus metabolites determined by SLOOP 31P NMR spectroscopy.

Meininger M, Landschütz W, Beer M, Seyfarth T, Horn M, Pabst T, Haase A, Hahn D, Neubauer S, von Kienlin M.

Magn Reson Med. 1999 Apr;41(4):657-63.

48.

Myocardial Na+ content after infarction during scar development.

Horn M, Weidensteiner C, Lanz T, Neubauer S, von Kienlin M.

MAGMA. 1998 Sep;6(2-3):179-80. No abstract available.

PMID:
9803405
49.

Concentration of human cardiac 31P-metabolites determined by SLOOP 31P-MRS.

Landschütz W, Meininger M, Beer M, Seyfarth T, Horn M, Pabst T, Haase A, Hahn D, Neubauer S, von Kienlin M.

MAGMA. 1998 Sep;6(2-3):155-6. No abstract available.

PMID:
9803396
50.

Assessment of myocardial viability with MR--the Würzburg perspective.

Sandstede J, Beer M, Meininger M, Bertsch G, Werner E, Pabst T, Kenn W, Neubauer S, von Kienlin M, Hahn D.

MAGMA. 1998 Sep;6(2-3):143-4. No abstract available.

PMID:
9803390

Supplemental Content

Loading ...
Support Center